Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
Ozempic, Wegovy and Other New Drugs Are Selected for Medicare's Price Negotiations
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf
Novo Nordisk Dives After Medicare Targets Ozempic, Wegovy For Price Cuts
Novo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.
Novo Suffers Wegovy Trial Setback as US Plans to Cut Price
Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new trial, adding to growing threats to the Danish company’s early dominance in the surging market for new weight-loss treatments.
Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out.
The two blockbusters Novo Nordisk medicines are among 15 additional drugs whose prices Medicare will be allowed to negotiate with drugmakers.
1d
on MSN
The FDA Proposes a De Facto Cigarette Ban, Which Would Expand the Disastrous War on Drugs
On its way out the door, the Biden administration has proposed a rule that would effectively ban cigarettes by requiring a ...
1h
The end of Bidenomics, DOJ sues Walgreens: Market Domination Overtime
Alexandra Canal and Josh Lipton examine the top stories on Wall Street after Friday's closing bell. The US Department of ...
2d
on MSN
NYC to Open 2,200-Bed Migrant Shelter for Single Men Near Open-Air Drug Market
Retrofitting the building for the new shelter will reportedly cost the Democrat-run sanctuary city between $250,000 and ...
18h
Sandwell has one of the lowest rates of drug-related deaths in the country, according to new data.
Sandwell has one of the lowest rates of drug-related deaths in the country, according to new data. The council says the low ...
Crain's New York
1d
Midtown-based drug company raises $23M in attempt to defy aging
A Midtown-based therapeutics company hopes to tap the growing market of anti-aging drugs with a suite of pharmaceutical ...
2d
on MSN
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...
1d
US FDA grants first market authorization of nicotine pouches to Zyn
The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...
1d
Wockhardt’s ‘miracle drug’ Zaynich: Can it revive the antibiotics market and the company’s fortunes?
Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...
NOLA.com
3d
Can weight loss drugs curb alcohol addictions? New research looks at the possibility.
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback